Wright Aims To Transcend Supplier GMP Issues Following Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
Wright Medical cites its Lineage ceramic-on-ceramic hip replacement system as an example of the type of product differentiation the firm plans to pursue in order to compete in an increasingly consolidated market
You may also be interested in...
Wright Medical Warning Letter Reveals Inspection Violations, Adverse Events
Wright Medical PMA primary efficacy data included patients implanted with another manufacturer's hip component, FDA states in a recent warning letter to the firm
Wright Medical Warning Letter Reveals Inspection Violations, Adverse Events
Wright Medical PMA primary efficacy data included patients implanted with another manufacturer's hip component, FDA states in a recent warning letter to the firm
Wright Medical Projects Earnings Growth On Par With Large-Cap Ortho Firms
Wright Medical plans to increase its U.S. direct sales force by 20% to bolster marketing in its orthopedic biologics and extremities segments in anticipation of product approvals in 2004